Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2020-07-31 AGM Information
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
200730 PR AGM EGM II invitation NL_FINAL.pdf
AGM Information Classification · 98% confidence The document is titled "Oproeping tot de Buitengewone Algemene Aandeelhoudersvergadering" (Call for the Extraordinary General Shareholders' Meeting) and explicitly invites shareholders to attend a meeting on September 2, 2020. This document serves as the official notice or invitation for a general meeting of shareholders. This aligns directly with the definition of materials shared during an Annual General Meeting (AGM) or an Extraordinary General Meeting (EGM). The closest specific category provided is 'AGM Information' (AGM-R), which covers presentations and materials shared during the AGM. While this is a 'call' rather than the meeting materials themselves, in the context of the provided definitions, it is the most appropriate classification for formal meeting notices, especially when considering that DEF 14A (Proxy) and DVA (Voting Results) are separate categories. Since it is a formal notice for a general meeting, AGM-R is the best fit.
2020-07-31 Dutch
2020 AGM - Minutes (final) (ENG)_WEBSITE.pdf
AGM Information Classification · 99% confidence The document explicitly states in the main heading that it contains the "MINUTES OF THE ANNUAL SHAREHOLDERS' MEETING HELD ON 8 MAY 2020". The content details the opening, agenda items (including approval of financial statements, discharge of directors, and director appointments), and the process of voting and attendance, which are all characteristic components of the official minutes recorded during an Annual General Meeting (AGM). This aligns directly with the definition for AGM Information (AGM-R).
2020-05-08 English
2020 AGM - Minutes (final) (DUT)_WEBSITE.pdf
AGM Information Classification · 100% confidence The document text is explicitly titled "NOTULEN VAN DE GEWONE ALGEMENE VERGADERING VAN AANDEELHOUDERS GEHOUDEN OP 8 MEI 2020" (MINUTES OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS HELD ON MAY 8, 2020). The content details the opening of the meeting, the agenda items (including approval of annual accounts, remuneration report, and reappointment/appointment of directors), and the formal record of proceedings. This directly corresponds to the documentation generated from an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2020-05-08 Dutch
EGM 2020 - Minutes (final) (DUT)_OK.pdf
AGM Information Classification · 96% confidence The document is a notarial record ('akte') detailing the proceedings of an 'buitengewone algemene vergadering' (Extraordinary General Meeting) of the company 'BIOCARTIS GROUP'. The key topics discussed involve 'Statutenwijzigingen' (Statute amendments) and the renewal of the Board of Directors' authorization to increase capital ('hernieuwing van het toegestane kapitaal'). This type of document, which records the decisions and minutes of a shareholder meeting, specifically relates to the formal governance and shareholder decision-making process. Since the content is the minutes/record of the meeting itself, and it deals with fundamental corporate governance (statutes, capital authorization), it aligns best with the concept of an Annual General Meeting (AGM) record, even though it is an Extraordinary one, as AGM-R covers presentations and materials shared during the AGM. Given the context of Belgian corporate law documents detailing shareholder meetings, AGM-R is the most appropriate fit among the provided codes, as it captures the essence of formal shareholder assembly documentation.
2020-05-08 Dutch
200422 Biocartis Q1 2020 Business Update_ENG_FINAL.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a 'Business Update' for Q1 2020, which functions as an interim financial and operational performance report. It contains specific financial data (cartridge volume growth, cash position), management commentary, and operational highlights. It is not a full Annual Report (10-K) nor a simple announcement of a report (RPA), as it provides substantive financial and business analysis for a specific fiscal period (Q1 2020). Therefore, it is classified as an Interim/Quarterly Report. Q1 2020
2020-04-23 English
200422 Biocartis Q1 2020 Business Update_NL_FINAL.pdf
Earnings Release Classification · 98% confidence The document is titled "BIOCARTIS Q1 2020 BUSINESS UPDATE" and is explicitly labeled as a "PERSBERICHT GEREGLEMENTEERDE INFORMATIE" (Press Release Regulated Information). It details key commercial metrics (cartridge volume, installed base), partnership updates (AstraZeneca, BMS, Immunexpress), product development (SARS-CoV-2 test), and provides updated financial outlook/guidance suspension for the full year 2020, all based on the first quarter (Q1) results. This structure—a summary of operational and financial highlights for a specific interim period (Q1) released via a press release—is characteristic of an Earnings Release (ER). Although it contains some forward-looking statements and management commentary, its primary function is the initial announcement of period results, not the comprehensive financial statements found in an Interim Report (IR) or Annual Report (10-K). The document also announces a management change (new CFO), but the overall context is the quarterly performance update. Q1 2020
2020-04-23 Dutch

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.